Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity - Wikidata - awgldk - TriplyDB

Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity

Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity

http://www.wikidata.org/entity/Q24652244

about

Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation Minor histocompatibility antigens: past, present, and future.Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.Allo-reactive T cells for the treatment of hematological malignancies.Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover.Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation.Natural T-cell ligands that are created by genetic variants can be transferred between cells by extracellular vesicles

P2860

Q26750999-1014F0BC-DC0C-4F87-B893-3261F3899CD1 Q34163218-81C8C9A5-A271-4714-AD3C-91323A2356C4 Q34196623-B1CB6410-7B78-43E8-94DA-B059BDB6B41B Q36979992-9300F7FE-0407-4B22-BE54-259E7D1ADC98 Q36994811-E53BA076-12B2-4115-932D-C742529CAF4E Q37552067-6DFF496E-882C-4C60-8205-52C0EA42A60C Q38254976-D19468FD-D222-43F3-B89A-DCBFCF067C6E Q38616461-523710F5-7CD8-4074-9B24-CA5A7E5308C4 Q38636565-91950EF9-FAEA-4E03-B945-20FE4A5FA82C Q39011409-5F25F3D0-2320-4951-8F17-A36E0B25EA96 Q39564229-FC4920DD-46DE-49F5-9845-B8D8EC665997 Q42633041-1411193D-A337-40CA-8A1C-85796AE9CAC8 Q58697791-4C98478E-32EC-43F4-92F6-9C1EF6C0EFAB

P2860

Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity

http://www.wikidata.org/entity/Q24652244

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Identification of phosphatidyl ...... aft versus leukemia reactivity

@ast

Identification of phosphatidyl ...... aft versus leukemia reactivity

@en

Identification of phosphatidyl ...... aft versus leukemia reactivity

@nl

type

label

Identification of phosphatidyl ...... aft versus leukemia reactivity

@ast

Identification of phosphatidyl ...... aft versus leukemia reactivity

@en

Identification of phosphatidyl ...... aft versus leukemia reactivity

@nl

prefLabel

Identification of phosphatidyl ...... aft versus leukemia reactivity

@ast

Identification of phosphatidyl ...... aft versus leukemia reactivity

@en

Identification of phosphatidyl ...... aft versus leukemia reactivity

@nl

P1433

Q24652244-D02CF619-A0E0-421C-BE00-160AC0F71F04

P1476

Q24652244-03585A88-E897-418F-9628-1F04EB068853

P2093

Q24652244-7565C1F7-12F5-4674-B087-2EBC4978B945

Q24652244-8C3ED99A-1573-49D9-A253-F6C480DB5CF5

Q24652244-9EE099CC-E652-469A-9C4F-5CBAF235F260

Q24652244-BD083657-71BA-470B-B107-26626C1C3D21

Q24652244-C0D2C255-8EFB-408E-A2B8-F89EBC4E7366

Q24652244-D7D4C608-02E4-47CC-BAB1-4C9BE7929C08

Q24652244-DAD9C214-F6DF-4B30-B2C9-0EDF99BE5F5B

Q24652244-EF807DB7-3AA6-4307-8160-82E99C5AA8B4

Q24652244-F02DCDD5-00D6-46D1-8E0A-900497CEAAB7

P2860

Q24652244-020F7703-8B61-4181-A7E9-80AAC92D3322

Q24652244-12635430-FBEE-4311-A314-FE4FF6402DC6

Q24652244-14F84BB6-55D6-4499-8FEB-87CA81A15CC8

Q24652244-2E397A84-38B3-423D-AF95-3E988941BCEA

Q24652244-536B576B-22FE-479D-8CE3-786DD5EC76EC

Q24652244-6730C3DF-05CC-4877-85D5-323285566461

Q24652244-6EE42079-E0AB-4AEE-887E-425BA99AC466

Q24652244-727FECA3-B63D-40C4-8CEC-42DAB7632799

Q24652244-76A9151A-C657-481D-9FEF-BF248877AD19

Q24652244-8420B9B0-1AA9-432C-B63F-6B78A6696F5F

P304

Q24652244-A927EB6A-0BD5-45B2-B300-667C27DA8957

P31

Q24652244-3B745CBE-5E6E-45A3-A9E2-75593704A621

P356

Q24652244-2865BBFD-8031-44DB-8BB7-5F3C9F49E552

P407

Q24652244-43BD5192-0074-485D-9020-5127ADE1D483

P433

Q24652244-D9EA5AF1-5A3A-4992-861E-8FEB4909E158

P478

Q24652244-EF99C3E9-D16C-485D-8147-17DBCED3C9E1

P50

Q24652244-005C38A7-D373-4502-81E6-ACFBBEFDFFB3

P577

Q24652244-E2A6505D-7EF8-48E1-A10A-4A1FB98249AA

P5875

Q24652244-27EFC7CF-B55C-4B6F-B8A5-5322B2907171

P698

Q24652244-1CB17D51-14F3-40A6-A11E-40378914D9CD

P921

Q24652244-89EFFBF1-B092-462A-A3FC-EC80FF203A84

P932

Q24652244-675F400D-6E38-422A-A761-DC0C7E53D9C4

P356

PNAS.0712250105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Identification of phosphatidyl ...... aft versus leukemia reactivity

@en

P2093

Caroline E Rutten

http://www.w3.org/2001/XMLSchema#string

Edith D van der Meijden

http://www.w3.org/2001/XMLSchema#string

Elisabeth H Slager

http://www.w3.org/2001/XMLSchema#string

J H Frederik Falkenburg

http://www.w3.org/2001/XMLSchema#string

Johannes J van Rood

http://www.w3.org/2001/XMLSchema#string

M Willy Honders

http://www.w3.org/2001/XMLSchema#string

Peter A von dem Borne

http://www.w3.org/2001/XMLSchema#string

Roel Willemze

http://www.w3.org/2001/XMLSchema#string

Simone A P van Luxemburg-Heijs

http://www.w3.org/2001/XMLSchema#string

P2860

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

P304

3837-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0712250105

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Marieke Griffioen

P577

2008-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5534982

http://www.w3.org/2001/XMLSchema#string

P698

18316730

http://www.w3.org/2001/XMLSchema#string

P921

P932

2268788

http://www.w3.org/2001/XMLSchema#string